Home » Meetings » CHEST 2017
CHEST 2017
CHEST 2017
The ACCP just released new lung cancer screening guidelines.
Patients who develop pulmonary edema after starting prostacyclin for pulmonary arterial hypertension have a greater risk for mortality.
Patients with pulmonary arterial hypertension experienced better improvements in pulmonary arterial compliance with riociguat compared with phosphodiesterase type 5 inhibitors.
Researchers assessed the efficacy of a once-daily treatment option for controlled asthma.
In a retrospective analysis, researchers examined the efficacy of beta blocker therapy in prolonging patients’ lives.
Results indicate that further study of the relationship between the 6-minute walk distance test and functional capacity in PAH is necessary.
A 3-variable score that encompasses dyspnea score, prednisone use, and prior hospitalization for COPD exacerbations can predict mortality and readmission risk.
A recent study examined whether nebulized glycopyrrolate is safe to use in patients with severe COPD and comorbid cardiovascular risk factors.
The safety of concurrently administering nebulized glycopyrrolate with long-acting beta agonists was examined in 3 studies.
Load More
Open
Next post in CHEST 2017
Close
Close more info about Updated Lung Cancer Screening Guidelines Released at CHEST
Loading...
Close more info about Updated Lung Cancer Screening Guidelines Released at CHEST
Loading...